The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an ...

New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid ...

Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal ...

The results come from five patients enrolled in the biotech's ingoing phase 1/2 study of RGX-111 – which uses an adeno-associated viral vector (AAV9) to deliver a gene coding for an enzyme that ...

A viral vector is a carrier developed to inject genetic ... rare pediatric diseases and will produce adeno-associated virus (AAV9) vectors to provide to Child's Cure. Child's Cure plans to develop ...

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based inv ...